Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-04

Clinical Trial Update: An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh [NA]

View source ↗

Summary

A completed clinical trial evaluating the effectiveness of paromomycin administered by intramuscular injection for visceral leishmaniasis in Bangladesh.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paromomycin IM Injection (Paromomycin)

Snippet

Sponsor: PATH | Conditions: Visceral Leishmaniasis | NA | Status: COMPLETED